Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023

Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023
Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022

GlobeNewswire

January 03, 2023



SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments...

Related Keywords

United States ,Singapore ,San Francisco ,California ,American ,Steve Krognes ,Ivan Horak ,Dave Schemelia ,Jonathan Nugent ,Daniel Kontoh Boateng ,Darren Carroll ,Thomas Willemsen ,Amy Schulman ,Wilsonw Cheung ,Tessa Therapeutics Ltd ,Meeting Of The American Society Hematology ,Us Food Drug Administration ,Tessa Therapeutics Provides Strategic Outlook ,Corporate Update ,Annual Meeting ,American Society ,Chief Medical Officer ,Chief Scientific Officer ,Polaris Partners ,Tessa Therapeutics ,Epstein Barr Virus Specifict Cells ,Forward Looking ,Private Securities Litigation Reform Act ,Drug Administration ,Financial Officer ,